Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

ASKA Pharmaceutical Holdings Co Ltd (4886)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2,267.0 -27.0    -1.18%
02/05 - Closed. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3119660003 
  • Volume: 46,900
  • Bid/Ask: 2,263.0 / 2,273.0
  • Day's Range: 2,235.0 - 2,289.0
ASKA Pharmaceutical Holdings Co 2,267.0 -27.0 -1.18%

4886 Balance Sheet

 
Featured here, the Balance Sheet for ASKA Pharmaceutical Holdings Co Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 61959 59644 55043 53759
Cash and Short Term Investments 20354 20346 18083 17905
Cash - - - -
Cash & Equivalents 17454 17446 15183 14505
Short Term Investments 2900 2900 2900 3400
Total Receivables, Net 18307 17343 16370 15217
Accounts Receivables - Trade, Net 18307 17343 16370 15217
Total Inventory 19713 18586 17501 17687
Prepaid Expenses - - - -
Other Current Assets, Total 3585 3369 3089 2950
Total Assets 94857 91920 89166 87138
Property/Plant/Equipment, Total - Net 10594 10649 10698 10796
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net - - - -
Intangibles, Net 3180 3615 4018 4465
Long Term Investments 19122 18011 19406 16400
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 2 1 1 1
Other Assets, Total 7891 7512 7120 10537
Total Current Liabilities 21520 20036 18673 17650
Accounts Payable 8638 7447 7520 5860
Payable/Accrued - - - -
Accrued Expenses - 1143 - 1166
Notes Payable/Short Term Debt 3180 2980 2885 300
Current Port. of LT Debt/Capital Leases - - - 3138
Other Current liabilities, Total 9702 8466 8268 7186
Total Liabilities 34466 33300 32286 32605
Total Long Term Debt 6925 7345 7765 9185
Long Term Debt 6925 7345 7765 9185
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total 2841 -7086 -7187 -6853
Total Equity 60391 58620 56880 54533
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 1197 1197 1197 1197
Additional Paid-In Capital 1848 1848 1847 1847
Retained Earnings (Accumulated Deficit) 55284 53522 50821 49619
Treasury Stock - Common -3287 -3287 -3340 -3350
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 5349 5340 6355 5220
Total Liabilities & Shareholders' Equity 94857 91920 89166 87138
Total Common Shares Outstanding 28.33 28.33 28.29 28.29
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4886 Comments

Write your thoughts about ASKA Pharmaceutical Holdings Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email